| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/03/2011 | CA2415010C Propane-1,3-dione derivatives useful as gnrh receptor antagonist |
| 05/03/2011 | CA2378586C Replication-competent anti-cancer vectors |
| 05/03/2011 | CA2346564C Oxaliplatinum preparation packaging |
| 05/03/2011 | CA2293805C Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 04/29/2011 | CA2741429A1 Process for preparing chlorins and their pharmaceutical uses |
| 04/29/2011 | CA2708489A1 Use of cabazitaxel and a prednisone or a prednisolone in the treatment of prostate cancer |
| 04/28/2011 | WO2011050357A2 Protein arginine deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer |
| 04/28/2011 | WO2011050302A2 Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment |
| 04/28/2011 | WO2011050263A2 Systemic immunosuppression in the treatment of age related macular degeneration and diabetic retinopathy |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011050206A2 Compositions and methods for the treatment of sinonasal disorders |
| 04/28/2011 | WO2011050178A2 Targeted prdm gene or protein modulation therapeutic agents |
| 04/28/2011 | WO2011050120A1 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity |
| 04/28/2011 | WO2011050068A2 Bivalent diazo bicyclic smac mimetics and the uses thereof |
| 04/28/2011 | WO2011050016A1 Akt inhibitors |
| 04/28/2011 | WO2011050000A2 Single molecule nucleic acid nanoparticles |
| 04/28/2011 | WO2011049979A2 Injectable formulations for intra- articular or peri-articular administration |
| 04/28/2011 | WO2011049972A1 Nanoparticles for drug delivery |
| 04/28/2011 | WO2011049960A2 Compositions and methods for the treatment of sinonasal disorders |
| 04/28/2011 | WO2011049946A1 Combination cancer therapy with hsp90 inhibitory compounds |
| 04/28/2011 | WO2011049868A1 Modulators of hepatocyte growth factor activator |
| 04/28/2011 | WO2011049810A2 Compositions and methods for treating inflammation and fibrosis |
| 04/28/2011 | WO2011049758A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2011 | WO2011049722A1 PYRAZOLO [3,4-b] PYRIDIN-4-ONE KINASE INHIBITORS |
| 04/28/2011 | WO2011049659A2 Novel use and method of rapamycin to treat toxic shock |
| 04/28/2011 | WO2011049474A1 Salts of imatinib with tartaric acids |
| 04/28/2011 | WO2011049412A2 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells |
| 04/28/2011 | WO2011049405A2 Optical imaging contrast agent, use and device thereof |
| 04/28/2011 | WO2011049332A2 2,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors |
| 04/28/2011 | WO2011049289A2 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells |
| 04/28/2011 | WO2011049274A1 Imidazole derivatives and compositions for treating melanoma |
| 04/28/2011 | WO2011049256A1 Photosensitizer/metal nanoparticle charge complex and composition containing the complex for photodynamic therapy or diagnosis |
| 04/28/2011 | WO2011049154A1 Agent for reducing risk of developing cancer |
| 04/28/2011 | WO2011049082A1 INTEGRIN α8Β1-SPECIFIC MONOCLONAL ANTIBODY |
| 04/28/2011 | WO2011049059A1 Composition comprising rna-enclosing carrier |
| 04/28/2011 | WO2011049042A1 Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient |
| 04/28/2011 | WO2011048936A1 Aminothiazole derivative |
| 04/28/2011 | WO2011048445A1 Inhibitors of guanine exchange factors and their use as anticancer drugs |
| 04/28/2011 | WO2011048409A1 Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 04/28/2011 | WO2011048111A1 Compounds |
| 04/28/2011 | WO2011048082A1 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors |
| 04/28/2011 | WO2011047926A1 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents |
| 04/28/2011 | WO2011047796A1 Substituted halophenoxybenzamide derivatives |
| 04/28/2011 | WO2011047795A1 Substituted benzosulphonamides |
| 04/28/2011 | WO2011047788A1 Substituted benzosulphonamides |
| 04/28/2011 | WO2011047770A2 Pyrazolopyrimidine derivatives |
| 04/28/2011 | WO2011047639A1 Pharmaceutical solution of taxanes comprising chelating agent and preparation method thereof |
| 04/28/2011 | WO2011047637A1 Pharmaceutical solution of taxanes comprising ph regulator and preparation method thereof |
| 04/28/2011 | WO2011047636A1 Pharmaceutical solution of taxanes comprising solubilizer and preparation method thereof |
| 04/28/2011 | WO2011047631A1 Proteins or polypeptides with cd137l function and genes encoding the same and uses thereof |
| 04/28/2011 | WO2011047518A1 Enteral nutrition comprising marine bioactive polysaccharide, preparation method and use thereof |
| 04/28/2011 | WO2011047515A1 Indenoisoquinolinone derivatives, manufacturing method and medical use thereof. |
| 04/28/2011 | WO2011047434A1 A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | WO2011032003A9 Immunization to reduce neurotoxicity during treatment with cytolytic viruses |
| 04/28/2011 | WO2011014009A3 Novel di-substituted phenoxyacetyl-based compound or pharmaceutically acceptable salt thereof, production method for same and pharmaceutical composition for suppressing multiple drug resistance comprising same as an active ingredient |
| 04/28/2011 | WO2011008543A3 Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal |
| 04/28/2011 | WO2011005377A3 Compositions and methods comprising vegfr-2 and vegfr-3 antagonists for the treatment of metastatic disease |
| 04/28/2011 | WO2010150275A3 Method of extraction from withania somnifera and one or more fractions containing pharmacologically active ingredients obtained therefrom |
| 04/28/2011 | WO2010144846A3 Gastrointestinal disease or disorder imaging and treatment |
| 04/28/2011 | WO2010138955A3 Methods and compositions for treating neoplasia |
| 04/28/2011 | WO2010129895A3 Cd133 epitopes |
| 04/28/2011 | WO2010089128A3 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| 04/28/2011 | WO2010086454A9 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases |
| 04/28/2011 | WO2009019616A3 Isoprekinamycin analogs and syntheses thereof |
| 04/28/2011 | WO2009004496A3 Bisanthrapyrazoles as anti-cancer agents |
| 04/28/2011 | WO2008070943A3 Soluble dimerized or oligomerized endostatin |
| 04/28/2011 | WO2006018221A9 Dihydropteridinone infusion solution having a long shelf life |
| 04/28/2011 | US20110099647 Antibodies against cd38 for treatment of multiple myeloma |
| 04/28/2011 | US20110098640 Visual indication of rupture of drug reservoir |
| 04/28/2011 | US20110098362 Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization |
| 04/28/2011 | US20110098361 Composition to enhance the bioavailability of curcumin |
| 04/28/2011 | US20110098350 Substituted cyclohexylidene-ethylidene-octahydro-indene compounds |
| 04/28/2011 | US20110098346 Nucleic acid molecule and method of targeting gene expression to gliomas |
| 04/28/2011 | US20110098341 Use of id4 for diagnosis and treatment of cancer |
| 04/28/2011 | US20110098339 C2orf18 as target gene for cancer therapy and diagnosis |
| 04/28/2011 | US20110098325 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 04/28/2011 | US20110098318 Farnesyl protein transferase inhibitors for treating breast cancer |
| 04/28/2011 | US20110098317 Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer |
| 04/28/2011 | US20110098310 Novel compounds, use and preparation thereof |
| 04/28/2011 | US20110098305 Arylsulfonamide compounds, compositions and methods of use |
| 04/28/2011 | US20110098302 Cyclic diaryl ether compounds as antagonists of prostaglandin d2 receptors |
| 04/28/2011 | US20110098301 Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders |
| 04/28/2011 | US20110098296 Thiazole And Oxazole Kinase Inhibitors |
| 04/28/2011 | US20110098294 Purine analogs |
| 04/28/2011 | US20110098293 Inhibitors of Protein Tyrosine Kinase Activity |
| 04/28/2011 | US20110098291 Antagonist of smoothened |
| 04/28/2011 | US20110098290 Pharmaceutical compounds |
| 04/28/2011 | US20110098283 3-cinnolinecarboxamide derivatives and their use for treating cancer |
| 04/28/2011 | US20110098280 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 04/28/2011 | US20110098275 5-alkynyl-pyridines |
| 04/28/2011 | US20110098274 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/28/2011 | US20110098271 Chromenone derivatives |
| 04/28/2011 | US20110098270 Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| 04/28/2011 | US20110098268 Spirocyclic compounds |
| 04/28/2011 | US20110098264 Pharmaceutical composition containing cyclometalated n-heterocyclic carbene complexes for cancer treatment |
| 04/28/2011 | US20110098263 Hydroxy-substituted cold(iii) porphyrin complexes as histone deacetylase inhibitors |
| 04/28/2011 | US20110098260 Steroid Compounds and Formulations |
| 04/28/2011 | US20110098257 Derivatives of 4- or 5-aminosalicylic acid |
| 04/28/2011 | US20110098254 Compositions comprising phospholipids |